Prof. Vinicio A. de Jesus Perez

Stanford University, USA

Assistant Professor of Medicine



2011 Assistant Professor of Medicine, Stanford University
2006 Instructor in Pulmonary/Critical Care, Stanford University

2006 Fellowship, Stanford University

2004 Fellowship, Stanford University

2003 Fellowship, University of Colorado Health Sciences Center

2001 Medical Residency, Massachusetts General Hospital

2000 Medical Internship, Massachusetts General Hospital


  1. G. Hansmann, R.A. Wagner, S. Schellong, V. de Jesus Perez, T. Urashima, L. Wang, A.Y. Sheikh, R.S. Suen, D.J. Stewart, and M. Rabinovitch.  Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator activated receptor- activation.   Circulation 2007 Mar 13; 115(10): 1275-84 (PMID: 17339547).
  2. G.Hansmann, V. de Jesus Perez, T.P. Alastalo, C. Alvira, C. Guignabert,  J. Bekker, S. Schellong, T. Urashima, L. Wang, N. Morrell and M. Rabinovitch.  An antiproliferative BMP-2/PPARg/ApoE axis in human and murine SMC and its role in pulmonary hypertension.  Journal of Clinical Investigation 2008; 118(5) 1846-57 (PMID: 18382765).
  3. V. de Jesus Perez, J. Swigris and S. Ruoss. Coexistence of primary adenocarcinoma of the lung and Tsukamurella infection.Journal of Medical Case Reports 2008; 207:2 (PMID: 18554413).
  4. V. de Jesus Perez, T.P. Alastalo, J. Wu, J. Axelrod, J. Cooke, M. Amieva and M. Rabinovitch Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta catenin and Wnt-RhoA-Rac1 pathways.   Journal of Cell Biology 2009; 184:1:83-99 (PMID: 19139264).
  5. V. de Jesus Perez, F. Haddad, R. Vagelos, W. Fearon, J. Feinstein and R.T. Zamanian. Angina Associated with left main coronary artery compression in pulmonary hypertension.   Journal of Heart and Lung Transplantation, 2009; May 8(5): 527-530 (PMID: 19416787).
  6. E. Spiekerkoetter, C. Guignabert, V. de Jesus Perez, T.P. Alastalo, J. Bekker, L. Wang, A. Lawrie, A. Schmidt, M. Berryman, R. Ashley and M. Rabinovitch.  S100A4 and BMP-2 co-dependently induce smooth muscle cell migration via pERK and Chloride intracellular Channel 4.Circulation Research 2009, Sep 25; 105(7):639-47 (PMID: 19713532).
  7. J. Wu, A. Chruscinski, V. de Jesus Perez, H. Singh, M. Pitsiouni, M. Rabinovitch, P. Utz and J. Cooke.  The Cholinergic modulation of angiogenesis: role of the 7 nicotinic     Acetylcholine receptor. J Cell Biochem. 2009 Oct 1; 108(2): 433-46 (PMID: 19623583).
  8. V. de Jesus Perez, K.T. Kudelko, S. Snook and R.T. Zamanian. Drugs and toxins associated pulmonary arterial hypertension: lessons learned and challenges ahead. Int J Clin Pract 2011; (169): 8-10 (PMID: 21176010).
  9. S.M. Chandra, H. Razavi, J. Kim, R. Agrawal, R. Kundu, V. de Jesus Perez, R.T. Zamanian, T. Quertermous and H. J. Chun. Arterioscler Thromb Vasc Biol 2011 Jan 13 (PMID: 21233449).
  10. T.P. Alastalo, M. Li, V. de Jesus Perez, D. Pham, H. Sawada, J.K. Wang, M. Koskenvuo, L. Wang, B. Freeman, H. Chang and M. Rabinovitch. Disruption of PPARγ/β-catenin–mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.  JCI 2011, Aug 8 (PMID 21821917).
  11. F. Haddad, E. Fuh, T. Peterson, M. Skhiri, K. Kudelko, V. de Jesus Perez, W. Wilkenmayer, R. Doyle and R.T. Zamanian.Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure.  Journal of Cardiac Failure 2011 Vol 17 (7): 533-539 (PMID 21703524).
  12. V. de Jesus Perez and R.T Zamanian. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2011 Apr 28;364(17):1677 (PMID: 21524224).
  13. V. de Jesus Perez.  Making sense of the estrogen paradox in pulmonary hypertension. AJRCCM 2011 Vol 184 (6): 629-630 (PMID: 21920924).
  14. F. Haddad, T. Peterson, E, Fuh, K Kudelko, V. de Jesus Perez, M Skhiri, R. Vagelos , I. Schnittger, AY Denault, DN Rosenthal, R Doyle and RT Zamanian. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension.  Circ Heart Fail. 2011; 4 (6): 692-9 (PMID 21908596).
  15. F. Haddad, K. Kudelko, O. Mercier, B. Vrtovec, RT Zamanian and V. de Jesus Perez. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.  Prog Cardiovasc Dis. 2011 Sep-Oct; 54 (2): 154-67 (PMID: 21875514).
  16. E. Ayala, K. Kudelko, F. Haddad, R.T. Zamanian and V. de Jesus Perez. The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure.  Chest. 2012; 141 (6): 1598-600 (PubMedID: 22670022).
  17. V. de Jesus Perez, F. Haddad and R.T. Zamanian. Diagnosis andManagement of pulmonary hypertension associated with left ventricular diastolic dysfunction.  Pulmonary Circulation. 2012; 2 (2): 163.
  18. V. de Jesus Perez, K. Yuan, M.E. Orcholski, H. Sawada, M. Zhao, C.G. Li, N.F. Tojais, N.P. Nickel, V. Rajagopalan, E.Spiekerkoetter, L. Wang, R. Dutta, D. Bernstein and M. Rabinovitch. Loss of Adenomatous Poliposis Coli-α3 Integrin Interaction Promotes Endothelial Apoptosis in Mice and Humans. Circulation Research. 2012 Sep 25.
  19. V. de Jesus Perez, E. Rosenzweig, L.J. Rubin, D. Poch, A. Bajwa, M. Park, M. Jain, R.C. Bourge, K. Kudelko, E. Spiekerkoetter, J. Liu, A. His and R.T. Zamanian. Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension. Am J Cardiol. 2012 Jul 30.
Free SCIRP Newsletters
Copyright © 2006-2023 Scientific Research Publishing Inc. All Rights Reserved.